# Retension Pharmaceuticals, Inc. — Form D

Retension Pharmaceuticals, Inc. of MCLEAN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-05. The offering totals $8.0M, of which $5.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-12-05
- Form: D
- Accession: 0002002988-23-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $5.8M
- Remaining: $2.2M
- Investors: 82
- Date of first sale: 2023-11-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498860

## Issuer

- Name: Retension Pharmaceuticals, Inc.
- CIK: 0002002988
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O REDUX THERAPEUTICS, LLC, MCLEAN, VA, 22101
- Phone: (703) 624-2024

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Eric Keller | Director | McLean, VA |
| Eric Keller | Executive Officer | McLean, VA |
| Michael Berendt | Director | McLean, VA |
| Donald Olds | Director | McLean, VA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-05-06](https://search.stillhousedata.com/formd/0002002988-25-000002) | D | $20.0M | $12.3M |
| [2024-05-15](https://search.stillhousedata.com/formd/0002002988-24-000001) | D/A | $11.0M | $10.1M |

## More

- [CIK 2002988 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2002988&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002002988-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.